Clinical Trials Logo

Haemostasis clinical trials

View clinical trials related to Haemostasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05986201 Completed - Haemostasis Clinical Trials

Assessment of Long-term Effects of Tachosil

Start date: February 1, 2016
Phase:
Study type: Observational

This study aimed to analyse the long-term effects of a carrier-bound fibrin sealant (CBFS) after abdominal surgery by following up patients years after application.

NCT ID: NCT03196297 Completed - Haemophilia A Clinical Trials

A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

explorerâ„¢5
Start date: August 16, 2017
Phase: Phase 2
Study type: Interventional

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to assess the efficacy of concizumab administered s.c. (subcutaneously, under the skin) once daily in preventing bleeding episodes in patients with severe haemophilia A without inhibitors.

NCT ID: NCT02568202 Completed - Clinical trials for Congenital Bleeding Disorder

Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Start date: September 2015
Phase: N/A
Study type: Observational

This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).

NCT ID: NCT01603342 Completed - Healthy Clinical Trials

A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers

Start date: December 2007
Phase: Phase 1
Study type: Interventional

This trial is conducted in the United States of America (USA). The aim of this trial is to determine the feasibility of demonstrating a quantifiable change from baseline in punch biopsy-induced bleeding durations and blood loss volumes in healthy subjects after receiving clopidogrel anti-platelet therapy.

NCT ID: NCT01561937 Completed - Healthy Clinical Trials

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

Start date: January 2007
Phase: Phase 1
Study type: Interventional

This trial is conducted in the United States of America (USA). The aim of this trial is to evaluate the efficacy of activated recombinant human factor VII to mitigate experimentally-induced bleeding in healthy volunteers treated with warfarin to reach a targeted INR (International Normalization Ratio).

NCT ID: NCT00440401 Completed - Haemorrhage Clinical Trials

TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)

Start date: February 2007
Phase: Phase 4
Study type: Interventional

To demonstrate efficacy and safety of TachoSil® in cardiovascular surgery